Drug Trial Radar · NCT06581406
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Last checked: Nov 19, 2026Latest source record: Apr 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
280
Planned (sponsor's estimate)
Start
Dec 17, 2024
Primary completion
Jan 2030
Study completion Oct 2031
Sponsor
- Lead sponsor
- Replimune, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 3, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to measure the clinical benefits of the combination of RP2 and nivolumab as compared with the combination of nivolumab and ipilimumab in patients with metastatic uveal melanoma who have not been treated with immune checkpoint inhibitor therapy.
Conditions
- Metastatic Uveal Melanoma
Interventions
RP2Biological
Genetically modified herpes simplex type 1 virus for tumor lysis and immune stimulation.
IpilimumabBiological
Ipilimumab: human cytotoxic T-lymphocyte antigen 4 (CTLA-4)-blocking antibody
NivolumabBiological
Nivolumab: Anti-PD-1 Monoclonal antibody
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: From Day 1 up to 3 years after last dose.
- Progression Free Survival (PFS)Time frame: From Day 1 up to 3 years after last dose.
Locations
33 sites in 3 countries. Site status is shown where the registry gives one.
HonorHealth Research Insisute
Scottsdale, Arizona · Recruiting
UC San Diego Moores Cancer Center
La Jolla, California · Recruiting
The Angeles Clinic and Research Institute
Los Angeles, California · Recruiting
University of California Los Angeles
Los Angeles, California · Recruiting
Stanford Cancer Institute
Palo Alto, California · Recruiting
University of Colorado Hospital - Anschutz Cancer Pavilion(ACP)
Aurora, Colorado · Recruiting
The Melanoma & Skin Cancer Institute
Englewood, Colorado · Recruiting
Georgetown University Medical Center
Washington D.C., District of Columbia · Recruiting
Mayo Clinic - Jacksonville FL
Jacksonville, Florida · Recruiting
Sylvester Comprehensive Cancer Center
Miami, Florida · Recruiting
Emory Winship Cancer Institute
Atlanta, Georgia · Recruiting
Northwestern Memorial Hospital
Chicago, Illinois · Recruiting
University of Chicago Medical Center
Chicago, Illinois · Recruiting
University of Iowa
Iowa City, Iowa · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Mayo Clinic Rochester
Rochester, Minnesota · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
Duke University Medical Center
Durham, North Carolina · Recruiting
The Ohio State University
Columbus, Ohio · Recruiting
Thomas Jefferson University
Philadelphia, Pennsylvania · Recruiting
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania · Recruiting
The West Clinic, PLLC dba West Cancer Center
Germantown, Tennessee · Recruiting
University of Tennessee Medical Center
Knoxville, Tennessee · Recruiting
Sarah Cannon Research Institute
Nashville, Tennessee · Recruiting
Vanderbilt Ingram Cancer Center (Henry-Joyce Cancer Clinic)
Nashville, Tennessee · Recruiting
UT Southwestern Medical Center
Dallas, Texas · Recruiting
The University Of Texas Md Anderson Cancer Center
Houston, Texas · Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington · Recruiting
University Of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin · Recruiting
Melanoma Institute Australia
Wollstonecraft, New South Wales, Australia · Recruiting
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia · Recruiting
The Royal Marsden NHS Foundation Trust
London, United Kingdom · Recruiting
The Clatterbridge Cancer Centre NHS Foundation Trust
Liverpool, Merseyside, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.